Markets:

Overview

News

Currencies

International

Treasuries

Eli Lilly (NY:LLY)

1,128.74 -0.61 (-0.05%)

Streaming Delayed Price Updated: 2:06 PM EDT, Jun 16, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Eli Lilly

< Previous 1 2 3 4 5 6 7 8 9

...

99 100 Next >

Eli Lilly vs. Novo Nordisk: Better Obesity Drug Stock? ↗

Today 13:20 EDT

These two healthcare leaders have a long history of competing against one another.

Via The Motley Fool

Health Care ETFs: XLV Delivers Low Fees and Solid Returns ↗

Today 9:07 EDT

Explore how portfolio concentration and stock count set these healthcare ETFs apart, impacting risk and diversification for investors seeking sector exposure.

Via The Motley Fool

Topics ETFs

Eli Lilly & Co. (NYSE:LLY): High Growth Momentum Meets Strong Technical Breakout Setup ↗

Today 7:50 EDT

Via Chartmill

FHLC vs. IYH: Which Healthcare ETF Is the Better Buy in 2026? ↗

Today 7:12 EDT

Portfolio size and stock selection set these healthcare ETFs apart and help shape their risk and return profiles.

Via The Motley Fool

Topics ETFs

Eli Lilly & Co (NYSE:LLY): An Affordable Growth Opportunity in the Pharmaceutical Sector ↗

June 11, 2026

Via Chartmill

3 Under-the-Radar Stocks to Buy and Hold for a Decade ↗

Today 3:50 EDT

All three could become highly prominent biotech companies within 10 years.

Via The Motley Fool

1 Profitable Stock to Target This Week and 2 We Avoid

Today 0:36 EDT

Even if a company is profitable, it doesn’t always mean it’s a great investment. Some struggle to maintain growth, face looming threats, or fail to reinvest ...

Via StockStory

Invesco's RSPH vs. PJP: Which Health Care ETF Is the Better Fund For The GLP-1 Revolution? ↗

June 15, 2026

Compare portfolio strategies, cost structures, and risk profiles as two Invesco healthcare ETFs take different paths to sector exposure.

Via The Motley Fool

Topics ETFs

Eli Lilly Eyes Label Expansion For Leukemia Drug ↗

June 15, 2026

Eli Lilly's Phase 3 BRUIN CLL-322 study showed Jaypirca combination therapy cut progression or death risk by 45% in CLL/SLL.

Via Benzinga

Should You Buy Eli Lilly Stock Now or Wait for a Dip? ↗

June 15, 2026

Eli Lilly has experienced robust growth, but investors may be thinking twice about the stock due to its high valuation.

Via The Motley Fool

Branded Pharmaceuticals Stocks Q1 Recap: Benchmarking Royalty Pharma (NASDAQ:RPRX)

June 14, 2026

As the Q1 earnings season wraps, let’s dig into this quarter’s best and worst performers in the branded pharmaceuticals industry, including Royalty Pharma (N...

Via StockStory

Topics Artificial Intelligence Intellectual Property

Pharmaceuticals Stocks Q1 Recap: Benchmarking Jazz Pharmaceuticals (NASDAQ:JAZZ)

June 14, 2026

Let’s dig into the relative performance of Jazz Pharmaceuticals (NASDAQ:JAZZ) and its peers as we unravel the now-completed Q1 pharmaceuticals earnings seaso...

Via StockStory

Topics Artificial Intelligence Intellectual Property

3 Reasons to Buy Eli Lilly Stock Like There's No Tomorrow ↗

June 14, 2026

Eli Lilly is winning the GLP-1 race right now, but it isn't resting on its laurels.

Via The Motley Fool

Meet the Spectacular Vanguard ETF That Could Buy SpaceX Stock as Soon as June 19 ↗

June 14, 2026

The Vanguard Mega Cap Growth ETF owns a concentrated portfolio of America's largest companies.

Via The Motley Fool

Topics ETFs

Pfizer's New Weight-Loss Data Just Gave Eli Lilly and Novo Nordisk Investors Something to Worry About ↗

June 12, 2026

The pharmaceutical company's flagship anti-obesity drug continues to bolster its efficacy and tolerability arguments.

Via The Motley Fool

These 3 Stocks With Fast-Growing Dividends Can Help You Beat Inflation ↗

June 12, 2026

Eli Lilly, Parker-Hannifin, and Microsoft all have grown their dividend by 50% or more over the past five years, but still have plenty of room for dividend growth.

Via The Motley Fool

Topics Economy

American Express, Live Nation And A Health Care Stock: CNBC's 'Final Trades' ↗

June 12, 2026

Eli Lilly and American Express are top picks on CNBC's Halftime Report Final Trades. Live Nation is on the verge of a new 52-week high.

Via Benzinga

AbbVie Reports Promising New Clinical Updates. Here's What It Means for the Company's Dividend. ↗

June 12, 2026

New cancer therapies may help fund dividend growth.

Via The Motley Fool

Topics Intellectual Property

Is Viking Therapeutics Stock Going to $100? ↗

June 12, 2026

Viking stock is known for soaring after positive news.

Via The Motley Fool

2 Cash-Producing Stocks on Our Buy List and 1 That Underwhelm

June 12, 2026

A company that generates cash isn’t automatically a winner. Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand. Cas...

Via StockStory

Why Pfizer Stock Popped Today ↗

June 11, 2026

Pfizer stock may not be cheap enough to buy yet, but it's certainly too cheap to sell.

Via The Motley Fool

2 Profitable Stocks for Long-Term Investors and 1 Facing Headwinds

June 09, 2026

Even if a company is profitable, it doesn’t always mean it’s a great investment. Some struggle to maintain growth, face looming threats, or fail to reinvest ...

Via StockStory

Why Eli Lilly Stock Climbed to a New All-Time High Today ↗

June 08, 2026

The pharma giant is well-positioned to lead the $200 billion global obesity treatment market.

Via The Motley Fool

Prediction: The Trump Bull Market Will Soon End -- But These 2 Stocks Will Keep Winning Anyway ↗

June 08, 2026

These stocks may deliver gains during any market environment.

Via The Motley Fool

Topics Artificial Intelligence Government Initial Public Offering

Lilly Just Announced 3 Infectious Disease Acquisitions in 1 Day. Is This the Beginning of Its Post-Obesity Growth Strategy? ↗

June 08, 2026

Infectious disease could fuel Eli Lilly's next growth phase.

Via The Motley Fool

Stock Market Today, June 8: Marvell, Intel, and Micron Lead Tech Stock Rebound ↗

June 08, 2026

Marvell’s leap into the S&P 500 caps a sharp AI-chip rebound that helped steady U.S. stocks, today, June 8, 2026.

Via The Motley Fool

Topics Artificial Intelligence Economy Stocks

Why Eli Lilly (LLY) Stock Is Up Today

June 08, 2026

What Happened? Shares of global pharmaceutical company Eli Lilly (NYSE:LLY) jumped 2.1% in the afternoon session after the company reported positive Phase 3 ...

Via StockStory

Why Eli Lilly, In A Buy Zone, Is Still The 'Clear Winner' Of The 'Weight Loss Olympics' ↗

June 08, 2026

Eli Lilly emerged as the "clear winner" from the ADA meeting last weekend in New Orleans, an analyst said following the event.

Via Investor's Business Daily

A Weight-Loss Rival Just Crashed 23%. Why That's Great News for Eli Lilly and Novo Nordisk. ↗

June 08, 2026

Zealand Pharma's stock is cratering today after disappointing results from a late-stage trial of its GLP-1 dual-receptor agonist drug.

Via The Motley Fool

Is the Vanguard Growth ETF (VUG) the Right Fit for Your Portfolio? ↗

June 08, 2026

How does an average annual gain of 18% over the past decade sound?

Via The Motley Fool

Topics ETFs

< Previous 1 2 3 4 5 6 7 8 9

...

99 100 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.